Research progress of exosomes from different sources in myocardial ischemia DOI Creative Commons
Huan Yan, Huang Ding,

Ruoxi Xie

et al.

Frontiers in Cardiovascular Medicine, Journal Year: 2024, Volume and Issue: 11

Published: Sept. 12, 2024

Ischemic heart disease refers to the imbalance between supply and demand of myocardial blood; it has various causes results in a class clinical diseases characterized by ischemia (MI). In recent years, incidence cardiovascular become higher higher, number patients with ischemic also increased year year. Traditional treatment methods include drug therapy surgical treatment, both which have limitations. The former maybe develop risks resistance more significant side effects, while latter may damage blood vessels risk infection. At this stage, new cell-free method needs be explored. Many research shown that exosomes from different cell sources can protect myocardium via intercellular action methods, such as promoting angiogenesis, inhibiting fibrosis, apoptosis pyroptosis, providing basis for MI. review, we briefly introduce formation consequences biology exosomes, then focus on role mechanism We discuss pretreated Chinese Western medicines ischemia. potential diagnostic markers therapeutic

Language: Английский

Navigating TAM receptor dynamics in tumour immunotherapy DOI Creative Commons

Jihao Yang,

Guanmin Chen,

Rui Wang

et al.

Cancer Immunology Immunotherapy, Journal Year: 2025, Volume and Issue: 74(5)

Published: March 15, 2025

Abstract The TAM receptor family is getting more and attention in the field of tumour immunity. Activation receptors not only aids survival multiplication cells but also increases their likelihood invading other spreading. In addition, activation helps to inhibit anti-tumour immune response, allowing evade surveillance. terms therapeutic strategies, a number inhibitors targeting are preclinical clinical development. Despite significant progress trials recent years, challenges remain. This review delves into kinetic characteristics family, dual role immunity, transmission process downstream signalling pathways. Based on this, we analysed summarised unique strategies combination therapies for regulating immunity using inhibitors. It elucidate key provides new perspectives future therapy.

Language: Английский

Citations

0

Exercise sensitizes PD-1/PD-L1 immunotherapy as a hypoxia modulator in the tumor microenvironment of melanoma DOI Creative Commons

Huiyu Yan,

Aimin Jiang, Yinong Huang

et al.

Frontiers in Immunology, Journal Year: 2023, Volume and Issue: 14

Published: Oct. 9, 2023

Introduction Hypoxia is associated with unfavorable prognoses in melanoma patients, and the limited response rates of patients to PD-1/PD-L1 blockade could be attributed immunosuppressive tumor microenvironment induced by hypoxia. Exercise offers numerous benefits anti-tumor process has potential alleviate hypoxia; however, precise mechanisms through which it exerts its effects remain unclear, presence synergistic immunotherapy yet definitively established. Methods We established a B16F10 homograft malignant model implemented two distinct exercise treatments (low/moderate-intensity swim) based on mice’s status. The specific function manner exercise-induced was determined RNA sequencing analysis changes microenvironment. Furthermore, moderate-intensity swim that exhibited superior suppression combined Anti-PD-1 treatment evaluate vivo efficacy mouse models. Results intervention yielded considerable effect impeding growth promoting apoptosis. Immunohistochemistry revealed improvements hypoxia down-regulation hypoxia-related pathways. Cellular immunofluorescence ELISA analyses demonstrated notable increase cytotoxic T cell amount decrease regulatory cells, indicating an improvement immune In comparison monotherapy, suppressive combination therapy found enhanced both hypoxic infiltration. Conclusion as modulator improving microenvironment, resulting promotion facilitation biologically safe sensitization immunotherapy.

Language: Английский

Citations

8

Residual OXPHOS is required to drive primary and metastatic lung tumours in an orthotopic breast cancer model DOI Creative Commons
Patries M. Herst,

Georgia Carson,

Danielle Lewthwaite

et al.

Frontiers in Oncology, Journal Year: 2024, Volume and Issue: 14

Published: May 1, 2024

Background Fast adaptation of glycolytic and mitochondrial energy pathways to changes in the tumour microenvironment is a hallmark cancer. Purely ρ 0 cells do not form primary tumours unless they acquire healthy mitochondria from their micro-environment. Here we explored effects severely compromised respiration on metastatic capability 4T1 mouse breast cancer cells. Methods cell lines with different levels respiratory capacity were generated; Seahorse extracellular flux analyser was used evaluate oxygen consumption rates, fluorescent confocal microscopy assess number SYBR gold-stained DNA nucleoids, presence ATP5B protein cytoplasm situ nuclear hybridization establish ploidy. MinION nanopore RNA sequence analysis compare transcription between lines. Orthotopic injection determine ability metastasize lungs female Balb/c mice. Results OXPHOS-deficient ATP5B-KO3.1 did generate tumours. Severely OXPHOS D5 generated both lung metastases. Cells metastasis OXPHOS-competent OXPHOS-compromised formed but no metastases when re-injected into significantly increased mtDNA content, this result capacity, which due decreased transcription. Gene set enrichment suggests that certain derived downregulate epithelial-to-mesenchymal related pathways. Conclusion In summary, required for tumorigenesis orthotopic model even very low are sufficient

Language: Английский

Citations

2

Interferon Gamma Inducible Protein 30: from biological functions to potential therapeutic target in cancers DOI
Sen Zhang,

Liwen Ren,

Li Wan

et al.

Cellular Oncology, Journal Year: 2024, Volume and Issue: 47(5), P. 1593 - 1605

Published: Aug. 14, 2024

Language: Английский

Citations

1

Research progress of exosomes from different sources in myocardial ischemia DOI Creative Commons
Huan Yan, Huang Ding,

Ruoxi Xie

et al.

Frontiers in Cardiovascular Medicine, Journal Year: 2024, Volume and Issue: 11

Published: Sept. 12, 2024

Ischemic heart disease refers to the imbalance between supply and demand of myocardial blood; it has various causes results in a class clinical diseases characterized by ischemia (MI). In recent years, incidence cardiovascular become higher higher, number patients with ischemic also increased year year. Traditional treatment methods include drug therapy surgical treatment, both which have limitations. The former maybe develop risks resistance more significant side effects, while latter may damage blood vessels risk infection. At this stage, new cell-free method needs be explored. Many research shown that exosomes from different cell sources can protect myocardium via intercellular action methods, such as promoting angiogenesis, inhibiting fibrosis, apoptosis pyroptosis, providing basis for MI. review, we briefly introduce formation consequences biology exosomes, then focus on role mechanism We discuss pretreated Chinese Western medicines ischemia. potential diagnostic markers therapeutic

Language: Английский

Citations

1